Associations between monocyte activation and collagen turnover biomarkers with subsequent clinical events in people with HIV – a nested case-control study among participants in the INSIGHT ESPRIT, FIRST, SMART, and START trials
Open Forum Infectious Diseases · 15.11.2026
DOI: 10.1093/ofid/ofag713 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 15.11.2026. Verfasst von Phyo Pyae Nyein und 11 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
While monocyte activation has been linked to cardiovascular disease (CVD) in people with HIV, its relationship with non-CVD comorbidities remains unclear. Similarly, the relationship between collagen turnover markers and HIV-related comorbidities has been understudied.
Methods
We conducted a case-control study among participants in the ESPRIT, FIRST, SMART, and START trials. Cases were participants who experienced a composite outcome of AIDS/AIDS-death (AIDS) or serious non-AIDS/non-AIDS death (SNA). Two matched controls were identified within trial by treatment group, age, and randomization date. Separate conditional logistic regression models (unadjusted and adjusted) estimated odds ratios (OR) for associations between baseline monocyte activation and collagen turnover markers with the composite and component outcomes.
Results
The cohort included 1487 participants: 498 cases, 989 controls. Median age was 44 years, 19% Black race, median CD4 count 539 cells/mm3. Cases included 189 AIDS, 324 SNA, 159 deaths, 168 cancer and 131 CVD. Higher levels of monocyte activation markers (sCD14, sCD163, MCP-1) were associated with higher odds of the composite (unadjusted ORs per 2-fold higher biomarker [95% CI]: 1.75 [1.37-2.24], 1.55 [1.31, 1.85], 1.67 [1.35, 2.07] respectively), largely driven by SNA. Associations remained significant after adjustments for sex, race, baseline CD4 and HIV RNA, D-dimer, IL-6, and hsCRP. Collagen turnover markers TIMP-1 and PIIINP were associated with the composite outcome but were no longer significant after adjusting for D-dimer, IL-6, and hsCRP.
Conclusions
In HIV-related comorbidities, monocyte activation may play a role independent of systemic inflammation and collagen deposition may reflect microscopic tissue injury associated with end-organ damage.
Zitieren
APA
Nyein, P. P., Sharma, S., Chen, L., Achhra, A., Helleberg, M., Kundro, M. A., Touloumi, G., Silva, M., Phillips, A. N., Baker, J. V., Matthews, G. V., & Dharan, N. J. (2026). Associations between monocyte activation and collagen turnover biomarkers with subsequent clinical events in people with HIV – a nested case-control study among participants in the INSIGHT ESPRIT, FIRST, SMART, and START trials. Open Forum Infectious Diseases. https://doi.org/10.1093/ofid/ofag713
Vancouver
Nyein PP, Sharma S, Chen L, Achhra A, Helleberg M, Kundro MA, et al. Associations between monocyte activation and collagen turnover biomarkers with subsequent clinical events in people with HIV – a nested case-control study among participants in the INSIGHT ESPRIT, FIRST, SMART, and START trials. Open Forum Infectious Diseases. 2026. doi:10.1093/ofid/ofag713
BibTeX
@article{Nyein2026,
author = {Nyein, Phyo Pyae and Sharma, Shweta and Chen, Larry and Achhra, Amit and Helleberg, Marie and Kundro, Mariana A and Touloumi, Giota and Silva, Milena and Phillips, Andrew N and Baker, Jason V and Matthews, Gail V and Dharan, Nila J},
title = {Associations between monocyte activation and collagen turnover biomarkers with subsequent clinical events in people with HIV – a nested case-control study among participants in the INSIGHT ESPRIT, FIRST, SMART, and START trials},
journal = {Open Forum Infectious Diseases},
year = {2026},
doi = {10.1093/ofid/ofag713}
}
EUVIMED